The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment
Open accessAbstract
Background and aims Pancreatic cancer organoids are tumor models of individualized human pancreatic ductal adenocarcinoma (PDA), created from surgical specimens and used for personalized treatment strategies. Unfortunately, most patients with PDA are not operative candidates. Creation of human PDA organoids at the time of initial tumor diagnosis is therefore critical. Our aim was to assess the feasibility of creating human PDA organoids by EUS fine-needle biopsy (EUS-FNB) sampling in patients with PDA.Methods In this prospective clinical trial in patients referred to evaluate a pancreatic mass, EUS-FNA was performed for initial onsite diagnosis. Two additional needle passes were performed with a 22-gauge FNB needle for organoid creation. Primary outcome was successful isolation of organoids within 2 weeks of EUS-FNB sampling (P0, no passages), confirmed by organoid morphology and positive genotyping.Results Thirty-seven patients with 38 PDA tumors were enrolled. Successful isolation of organoids (P0) was achieved in 33 of 38 tumors (87%). Establishment of PDA organoid lines for ≥5 passages of growth (P5, five passages) was reached in 25 of 38 tumors (66%). In the single patient with successful P5 FNB sampling-derived and P5 surgically derived organoids, there was identical matching of specimens. There were no serious adverse events. Two patients developed bleeding at the EUS-FNB puncture site requiring hemostasis clips.Conclusions Pancreatic cancer organoids can be successfully and rapidly created by means of EUS-FNB sampling using a 22-gauge needle at the time of initial diagnosis. Successful organoid generation is essential for precision medicine in patients with pancreatic cancer in whom most are not surgically resectable. (Clinical trial registration number: NCT03140592.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumor tissue, derived from either biopsies or surgical resections, is also typically processed akin to normal tissue to isolate tumour cells to grow as organoids16,49–51.”
From Organoids (2022) · cites this paper as [50]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tumor cells isolated from liquid samples such as peripheral blood52, ascites50,53, and pleural effusions54 can also be used as starting material to generate organoids.”
From Organoids (2022) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Self-citationHidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis
Hewitt, M. J., McPhail, M. J. W., Possamai, L. A., Dhar, A., Vlavianos, P., & Monahan, K. J. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.08.049 · Cited by 694
Organoids: A historical perspective of thinking in three dimensions
Simian, M., & Bissell, M. J. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610056 · Cited by 620
An In vivo Platform for Translational Drug Development in Pancreatic Cancer
Rubio‐Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio–Donahue, C. A., Karikari, C. A., Shi, C., Danenberg, K. D., Danenberg, P. V., Kuramochi, H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0113 · Cited by 422
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 383
Bang, J. Y., Hébert‐Magee, S., Trevino, J., Ramesh, J., & Varadarajulu, S. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.03.1392 · Cited by 269
Bang, J. Y., Hawes, R. H., & Varadarajulu, S. (2015) · Endoscopy · doi:10.1055/s-0034-1393354 · Cited by 235
Mihara, E., Hirai, H., Yamamoto, H., Tamura‐Kawakami, K., Matano, M., Kikuchi, A., Sato, T., & Takagi, J. (2016) · eLife · doi:10.7554/elife.11621 · Cited by 203
Lee, Y. K., Moon, J. H., Kim, H. J., Choi, H. S., Choi, M. H., Kim, D. W., Lee, T. H., Cha, S., Cho, Y., & Park, S. (2014) · Endoscopy · doi:10.1055/s-0034-1377558 · Cited by 149
Kim, G. H., Cho, Y. K., Kim, E. Y., Kim, H. K., Cho, J. W., Lee, T. H., Moon, J. S., & The Korean Eus Study Group (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.867361 · Cited by 137
Feasibility and efficiency of a new 22G core needle: a prospective comparison study
Hucl, T., Wee, E., Sekaran, A., Gupta, R., Ramchandani, M. J., Kalpala, R., Shrestha, R., Reddy, D. N., & Lakhtakia, S. (2013) · Endoscopy · doi:10.1055/s-0033-1344217 · Cited by 107
Preclinical models of pancreatic ductal adenocarcinoma
Hwang, C., Boj, S. F., Clevers, H. C., & Tuveson, D. A. (2015) · The Journal of Pathology · doi:10.1002/path.4651 · Cited by 105
Self-citationStrand, D. S., Jeffus, S. K., Sauer, B. G., Wang, A. Y., Stelow, E. B., & Shami, V. M. (2014) · Diagnostic Cytopathology · doi:10.1002/dc.23116 · Cited by 85
Wei, S., Lieberman, D. B., Morrissette, J. J. D., Baloch, Z. W., Roth, D. B., & McGrath, C. M. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21666 · Cited by 79
Model organoids provide new research opportunities for ductal pancreatic cancer
Boj, S. F., Hwang, C., Baker, L. A., Engle, D. D., Tuveson, D. A., & Clevers, H. C. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1014757 · Cited by 74
Self-citationMohamadnejad, M., Mullady, D., Early, D. S., Collins, B. T., Marshall, C. B., Sams, S. B., Yen, R. D., Rizeq, M. N., Romanas, M., Nawaz, S., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.12.018 · Cited by 66
Preclinical models of pancreatic ductal adenocarcinoma
Krempley, B. D., & Yu, K. H. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.06.15 · Cited by 52
Mavrogenis, G., Weynand, B., Sibille, A., Hassaini, H., Deprez, P. H., Gillain, C., & Warzée, P. (2014) · Endoscopy International Open · doi:10.1055/s-0034-1390889 · Cited by 44
Nagula, S., Pourmand, K., Aslanian, H. R., Bucobo, J. C., Gonda, T. A., Gonzalez, S., Goodman, A. J., Gross, S. A., Ho, S., DiMaio, C. J., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.013 · Cited by 44
Self-citationEndoscopic ultrasonography‐guided tissue acquisition: How to achieve excellence
Bhatia, V., & Varadarajulu, S. (2017) · Digestive Endoscopy · doi:10.1111/den.12823 · Cited by 39
Gleeson, F. C., Kipp, B. R., Kerr, S. E., Voss, J. S., Lazaridis, K. N., Katzka, D. A., & Levy, M. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.017 · Cited by 25
Endoscopic ultrasound guided fine needle tissue acquisition: Where we stand in 2013?
Karadsheh, Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2176 · Cited by 23
Diwakarla, C. S., Hannan, K. M., Hein, N., & Yip, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i13.2276 · Cited by 21
The Cancer Genomics Resource List 2014
Zutter, M. M., Bloom, K. J., Liang Cheng, C., Hagemann, I. S., Kaufman, J. H., Krasinskas, A. M., Lazar, A. J., Leonard, D. G. B., Lindeman, N. I., Moyer, A. M., et al. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0330-cp · Cited by 20
Kim, E. Y. (2014) · Clinical Endoscopy · doi:10.5946/ce.2014.47.5.425 · Cited by 14
Research works printed but not linked: 1
- Nagula, 2017, Comparing EUS-fine needle aspiration and EUS-fine needle biopsy for solid lesions: a multicenter, randomized trial, Clin Gastroenterol Hepatol. Epub
Cited by
Sorted by citations
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092
Self-citationZhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,082
Cancer modeling meets human organoid technology
Tuveson, D., & Clevers, H. (2019) · Science · doi:10.1126/science.aaw6985 · Cited by 935
Self-citationDisease modelling in human organoids
Lancaster, M. A., & Huch, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039347 · Cited by 390
Organoid technology and applications in cancer research
Xu, H., Lyu, X., Yi, M., Zhao, W., Song, Y., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0662-9 · Cited by 361
Metadata
- Authors
- Tiriac, H., Bucobo, J. C., Tzimas, D., Grewel, S., Lacomb, J. F., Rowehl, L. M., Nagula, S., Wu, M., Kim, J., Sasson, A., Vignesh, S., Martello, L., Munoz-Sagastibelza, M., Somma, J., Tuveson, D. A., Li, E., & Buscaglia, J. M.
- Affiliations
- Stony Brook School (US)
- SUNY Downstate Health Sciences University (US)
- Cold Spring Harbor Laboratory (US)
- Corresponding author
- Buscaglia, Jonathan M.
- ORCID
- Venue
- Gastrointestinal Endoscopy
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 87
- Issue
- 6
- Pages
- 1474-1480
- ISSN
- 0016-5107 (ISSN-L)
- PMC
- PMC6143289
- OpenAlex
- W2608725539
- Cited by
- 164
- References
- 30
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 20 · 2023: 12 · 2022: 31 · 2021: 26 · 2020: 30 · 2019: 17 · 2018: 9
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastrointestinal Endoscopy (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Funders
- Boston Scientific Corporation
- Stony Brook University
- National Institutes of Health (5p30ca045508-35)
- National Cancer Institute (P20CA192996, P50CA101955, R01CA188134, U10CA180944, P20CA192994, U01CA168409, P30-CA045508, R01CA190092)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- pancreatic ductal adenocarcinoma, pancreatic cancer organoids, EUS-guided fine-needle biopsy, precision oncology, precision medicine, unresectable pancreatic cancer, endoscopic ultrasound-guided fine-needle aspiration
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Organoids, Pancreatic Neoplasms, Tumor Cells, Cultured, Carcinoma, Pancreatic Ductal, Tissue Culture Techniques, Precision Medicine, Endoscopic Ultrasound-Guided Fine Needle Aspiration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
